Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/16906Share/Export:
CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
|
Talavera, K., Gees, M., Karashima, Y., Meseguer, V. M., Vanoirbeek, J. A. J., Damann, N., … Voets, T. (2009, September 13). Nicotine activates the chemosensory cation channel TRPA1. Nature Neuroscience. Springer Science and Business Media LLC. http://doi.org/10.1038/nn.2379 |
|
|
| Title: | Nicotine activates the chemosensory cation channel TRPA1 |
Authors: | Talavera, Karel; Gees, Maarten; Karashima, Yuji; Meseguer, Víctor M. CSIC ORCID CVN; Vanoirbeek, Jeroen A. J.; Damann, Nils; Everaerts, Wouter; Benoit, Melissa; Janssens, Annelies; Vennekens, Rudi; Viana, Félix CSIC ORCID ; Nemery, Benoit; Nilius, Bernd; Voets, Thomas | Issue Date: | 13-Sep-2009 | Publisher: | Nature Publishing Group | Citation: | Nature Neuroscience (2009), doi: 10.1038/nn.2379 (In press) | Abstract: | Topical application of nicotine, as used in nicotine replacement therapies, causes irritation of the mucosa and skin. This reaction has been attributed to activation of nicotinic acetylcholine receptors (nAChRs) in chemosensory neurons. In contrast with this view, we found that the chemosensory cation channel transient receptor potential A1 (TRPA1) is crucially involved in nicotine-induced irritation. We found that micromolar concentrations of nicotine activated heterologously expressed mouse and human TRPA1. Nicotine acted in a membrane-delimited manner, stabilizing the open state(s) and destabilizing the closed state(s) of the channel. In the presence of the general nAChR blocker hexamethonium, nociceptive neurons showed nicotine-induced responses that were strongly reduced in TRPA1-deficient mice. Finally, TRPA1 mediated the mouse airway constriction reflex to nasal instillation of nicotine. The identification of TRPA1 as a nicotine target suggests that existing models of nicotine-induced irritation should be revised and may facilitate the development of smoking cessation therapies with less adverse effects. | Description: | 8 pages, 7 figures.-- Supporting information available at: http://www.nature.com/neuro/journal/vaop/ncurrent/suppinfo/nn.2379_S1.html Article in press. |
Publisher version (URL): | http://dx.doi.org/10.1038/nn.2379 | URI: | http://hdl.handle.net/10261/16906 | DOI: | 10.1038/nn.2379 | ISSN: | 1097-6256 | E-ISSN: | 1546-1726 |
| Appears in Collections: | (IN) Artículos |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Nicotine_press_release.pdf | CSIC Press release (Spanish lang.) | 69,14 kB | Adobe PDF | ![]() View/Open |
CORE Recommender
SCOPUSTM
Citations
226
checked on Nov 16, 2025
WEB OF SCIENCETM
Citations
194
checked on Feb 26, 2024
Page view(s)
677
checked on Dec 9, 2025
Download(s)
316
checked on Dec 9, 2025
Google ScholarTM
Check
Altmetric
Altmetric
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.



CORE
